Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Trial Sites
Back to Top
Basic Trial Information
Trial Description
Summary
Further Trial Information
Eligibility Criteria
Trial Contact Information
| Phase | Type | Status | Age | Sponsor | Protocol IDs |
|---|---|---|---|---|---|
| No phase specified | Natural history/Epidemiology | Active | 18 and over | NCI, Other | GOG-0267 NCI-2011-02547, NCT01372787 |
Summary
RATIONALE: Studying quality of life in patients with cancer may help determine the effects of gynecologic cancer and may help improve the quality of life for future cancer survivors.
PURPOSE: This clinical trial studies the quality of life and care needs of patients with persistent or recurrent ovarian cancer, fallopian tube cancer, or peritoneal cancer.
Further Study Information
OBJECTIVES:
Primary
- To determine the prevalence and severity of patient-reported symptoms in patients with platinum-resistant ovarian, fallopian tube, and peritoneal cancers at study entry and at three and six months post-enrollment.
Secondary
- To explore the unmet needs of these women at study entry and at three and six months post-enrollment. (Exploratory)
- To explore the overall quality-of-life (QOL) of these women at study entry and at three and six months post enrollment. (Exploratory)
- To explore the relationship between patient-reported symptoms and overall QOL, current cancer therapy (yes/no), and treatment responses (if on cancer therapy). (Exploratory)
OUTLINE: This is a multicenter study.
Patients complete the Needs at the End-of-Life Screening Tool (NEST), the Functional Assessment of Cancer Therapy - Ovarian (FACT-O), the FACIT-Fatigue Subscale (FACIT-F), the National Comprehensive Cancer Network (NCCN) FACT Ovarian Symptom Index-18 (NFOSI-18), the FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort, and the FACT/GOG-Neurotoxicity (FACT/GOG-NTX) Scale quality-of-life questionnaires at baseline and at 3 and 6 months during office or clinic visits or via telephone or mail. Patients' demographic and therapy information, such as current age, ethnicity, marital status, employment status, prior chemotherapy regimens/cancer treatment, disease status (if available), performance status, patient care information, and current cancer therapy are also collected.
After completion of study participation, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
Eligibility Criteria
DISEASE CHARACTERISTICS:
- Patients with persistent or recurrent epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer
- Platinum-resistant (less than 6 months from date of last platinum therapy to date of first evidence of recurrent or persistent disease) disease as measured by any of the following:
- Imaging
- Physical exam
- CA-125 that is twice the upper limit of normal on two occasions with at least one week apart
- No patients who have platinum resistant or refractory disease after more than 6 months since prior therapy
- Criteria for patients on cancer therapy (e.g., chemotherapy, non-cytotoxic regimens, hormone therapy, or radiation therapy) include recurrent or persistent disease defined as having measurable disease per RECIST (Version 1.1)
- Patients not on chemotherapy are also eligible and are not required to have RECIST criteria
PATIENT CHARACTERISTICS:
- Life expectancy of at least 6 months
- Patients with any performance status, yet with the ability to verbally consent and participate in the first assessment
- Study measures will be administered in the office/clinic setting, or for study participants who are unable to attend clinics, via telephone or mail (telephone is the preferred back-up means)
- Patients may have or have had a prior non-gynecologic malignancy within 5 years prior to study enrollment; however, they must have completed all treatments for the disease and have no evidence of disease at the time of enrollment, and ovarian, peritoneal, or fallopian tube cancer must be the primary life-threatening diagnosis
- Patient must be able to read and write English
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No patients receiving chemotherapy for platinum-sensitive ovarian cancer, peritoneal, or fallopian tube cancer
Trial Lead Organizations/Sponsors
Gynecologic Oncology Group
National Cancer Institute| Vivian von Gruenigen |  | Principal Investigator |
Trial Sites
|
|
|
|
| U.S.A. | |||
|
|||
| Colorado | |||
|
|||
| Aurora | |||
|
|||
| University of Colorado Cancer Center at UC Health Sciences Center | |||
| Susan Davidson | Ph: 720-848-0650 | ||
| Connecticut | |||
|
|||
| Hartford | |||
|
|||
| Helen and Harry Gray Cancer Center at Hartford Hospital | |||
| James S. Hoffman | Ph: 860-224-5660 | ||
| Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| New Britain | |||
|
|||
| George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus | |||
| James S. Hoffman | Ph: 860-224-5660 | ||
| Hawaii | |||
|
|||
| Honolulu | |||
|
|||
| Cancer Research Center of Hawaii | |||
| Michael E. Carney | Ph: 808-983-6090 | ||
| Idaho | |||
|
|||
| Boise | |||
|
|||
| Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Illinois | |||
|
|||
| Chicago | |||
|
|||
| Robert H. Lurie Comprehensive Cancer Center at Northwestern University | |||
| Julian C. Schink | Ph: 312-695-1301 | ||
| Email: cancer@northwestern.edu | |||
| University of Chicago Cancer Research Center | |||
| Seiko Diane Yamada | Ph: 773-834-7424 | ||
| Evanston | |||
|
|||
| CCOP - Evanston | |||
| Jean A. Hurteau | Ph: 847-570-1381 | ||
| Urbana | |||
|
|||
| Carle Cancer Center at Carle Foundation Hospital | |||
| Kendrith M. Rowland | Ph: 800-446-5532 | ||
| Indiana | |||
|
|||
| Elkhart | |||
|
|||
| Elkhart Clinic, LLC | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Elkhart General Hospital | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Michiana Hematology-Oncology, PC - Elkhart | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Kokomo | |||
|
|||
| Community Cancer Care at Howard Regional Health System | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| La Porte | |||
|
|||
| Center for Cancer Therapy at LaPorte Hospital and Health Services | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Mishawaka | |||
|
|||
| Michiana Hematology-Oncology, PC - Mishawaka | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Saint Joseph's Medical Center | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Plymouth | |||
|
|||
| Michiana Hematology Oncology PC - Plymouth | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| South Bend | |||
|
|||
| CCOP - Northern Indiana CR Consortium | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Memorial Hospital of South Bend | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Michiana Hematology-Oncology, PC - South Bend | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Westville | |||
|
|||
| Michiana Hematology Oncology-PC Westville | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Iowa | |||
|
|||
| Ames | |||
|
|||
| McFarland Clinic, PC | |||
| Joseph James Merchant | Ph: 515-239-2621 | ||
| Des Moines | |||
|
|||
| CCOP - Iowa Oncology Research Association | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| John Stoddard Cancer Center at Iowa Lutheran Hospital | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| John Stoddard Cancer Center at Iowa Methodist Medical Center | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| Medical Oncology and Hematology Associates at John Stoddard Cancer Center | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| Medical Oncology and Hematology Associates at Mercy Cancer Center | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| Mercy Cancer Center at Mercy Medical Center - Des Moines | |||
| Robert J Behrens | Ph: 888-244-6061 | ||
| Email: sherrijr@iora.org | |||
| Kansas | |||
|
|||
| Chanute | |||
|
|||
| Cancer Center of Kansas, PA - Chanute | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Dodge City | |||
|
|||
| Cancer Center of Kansas, PA - Dodge City | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| El Dorado | |||
|
|||
| Cancer Center of Kansas, PA - El Dorado | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Fort Scott | |||
|
|||
| Cancer Center of Kansas - Fort Scott | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Independence | |||
|
|||
| Cancer Center of Kansas-Independence | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Kansas City | |||
|
|||
| Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center | |||
| Julia A. Chapman | Ph: 913-588-4709 | ||
| Kingman | |||
|
|||
| Cancer Center of Kansas, PA - Kingman | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Liberal | |||
|
|||
| Cancer Center of Kansas, PA - Liberal | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Newton | |||
|
|||
| Cancer Center of Kansas, PA - Newton | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Parsons | |||
|
|||
| Cancer Center of Kansas, PA - Parsons | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Pratt | |||
|
|||
| Cancer Center of Kansas, PA - Pratt | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Salina | |||
|
|||
| Cancer Center of Kansas, PA - Salina | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Wellington | |||
|
|||
| Cancer Center of Kansas, PA - Wellington | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Wichita | |||
|
|||
| Associates in Women's Health, PA - North Hillside | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Cancer Center of Kansas, PA - Medical Arts Tower | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Cancer Center of Kansas, PA - Wichita | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| CCOP - Wichita | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Via Christi Cancer Center at Via Christi Regional Medical Center | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Winfield | |||
|
|||
| Cancer Center of Kansas, PA - Winfield | |||
| Shaker R. Dakhil | Ph: 316-262-4467 | ||
| Kentucky | |||
|
|||
| Lexington | |||
|
|||
| Central Baptist Hospital | |||
| Hope M Cottrill | Ph: 859-260-6425 | ||
| Maine | |||
|
|||
| Portland | |||
|
|||
| Maine Medical Center - Bramhall Campus | |||
| Christopher J Darus | Ph: 207-885-7565 | ||
| Massachusetts | |||
|
|||
| Springfield | |||
|
|||
| Baystate Medical Center | |||
| Tashanna K Myers | Ph: 413-794-3565 | ||
| Email: tamara.wrenn@baystatehealth.org | |||
| Worcester | |||
|
|||
| Levine Cancer Center at UMass Medical Center - Memorial Campus | |||
| Susan L. Zweizig | Ph: 508-856-2464 | ||
| Email: laura.lefko@umassmed.edu | |||
| Michigan | |||
|
|||
| Ann Arbor | |||
|
|||
| CCOP - Michigan Cancer Research Consortium | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Saint Joseph Mercy Cancer Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| University of Michigan Comprehensive Cancer Center | |||
| Carolyn M. Johnston | Ph: 734-712-3456 | ||
| Dearborn | |||
|
|||
| Oakwood Cancer Center at Oakwood Hospital and Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Detroit | |||
|
|||
| Van Elslander Cancer Center at St. John Hospital and Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Wayne State University | |||
| Robert T. Morris | Ph: 313-576-9363 | ||
| Flint | |||
|
|||
| Hurley Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Grand Blanc | |||
|
|||
| Genesys Regional Medical Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Jackson | |||
|
|||
| Gayle M. Jacob Cancer Center at Allegiance Health | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Kalamazoo | |||
|
|||
| Borgess Medical Center | |||
| Raymond Sterling Lord | Ph: 269-373-7458 | ||
| Bronson Methodist Hospital | |||
| Raymond Sterling Lord | Ph: 269-373-7458 | ||
| West Michigan Cancer Center | |||
| Raymond Sterling Lord | Ph: 269-373-7458 | ||
| Lansing | |||
|
|||
| Sparrow Regional Cancer Center | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Livonia | |||
|
|||
| St. Mary Mercy Hospital | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Pontiac | |||
|
|||
| St. Joseph Mercy Oakland | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Port Huron | |||
|
|||
| Mercy Regional Cancer Center at Mercy Hospital | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Royal Oak | |||
|
|||
| William Beaumont Hospital - Royal Oak Campus | |||
| Jayson B Field | Ph: 248-551-7695 | ||
| Saginaw | |||
|
|||
| Seton Cancer Institute at Saint Mary's - Saginaw | |||
| Philip J. Stella | Ph: 734-712-3456 | ||
| Saint Joseph | |||
|
|||
| Lakeside Cancer Specialists, PLLC | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| St. Joseph | |||
|
|||
| Lakeland Regional Cancer Care Center - St. Joseph | |||
| Michael W. Method | Ph: 574-237-1328 | ||
| Minnesota | |||
|
|||
| Burnsville | |||
|
|||
| Fairview Ridges Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Coon Rapids | |||
|
|||
| Mercy and Unity Cancer Center at Mercy Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Edina | |||
|
|||
| Fairview Southdale Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Fridley | |||
|
|||
| Mercy and Unity Cancer Center at Unity Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Hutchinson | |||
|
|||
| Hutchinson Area Health Care | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Maplewood | |||
|
|||
| HealthEast Cancer Care at St. John's Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Minnesota Oncology - Maplewood | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Minneapolis | |||
|
|||
| Hennepin County Medical Center - Minneapolis | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Virginia Piper Cancer Institute at Abbott - Northwestern Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| New Ulm | |||
|
|||
| New Ulm Medical Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Robbinsdale | |||
|
|||
| Humphrey Cancer Center at North Memorial Outpatient Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Saint Louis Park | |||
|
|||
| CCOP - Metro-Minnesota | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Park Nicollet Cancer Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Saint Paul | |||
|
|||
| Regions Hospital Cancer Care Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| United Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Shakopee | |||
|
|||
| St. Francis Cancer Center at St. Francis Medical Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Stillwater | |||
|
|||
| Lakeview Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Waconia | |||
|
|||
| Ridgeview Medical Center | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Willmar | |||
|
|||
| Willmar Cancer Center at Rice Memorial Hospital | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Woodbury | |||
|
|||
| Minnesota Oncology - Woodbury | |||
| Daniel M Anderson | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
| Mississippi | |||
|
|||
| Jackson | |||
|
|||
| St. Dominic Cancer Center | |||
| Donald P Seago | Ph: 601-200-3300 | ||
| University of Mississippi Cancer Clinic | |||
| James Tate Thigpen | Ph: 601-815-6700 | ||
| Missouri | |||
|
|||
| Saint Louis | |||
|
|||
| Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis | |||
| David Gardner Mutch | Ph: 800-600-3606 | ||
| Email: info@ccadmin.wustl.edu | |||
| Springfield | |||
|
|||
| Cancer Research for the Ozarks | |||
| Robert L Carolla | Ph: 417-269-4520 | ||
| Hulston Cancer Center at Cox Medical Center South | |||
| Robert L Carolla | Ph: 417-269-4520 | ||
| St. John's Regional Health Center | |||
| Robert L Carolla | Ph: 417-269-4520 | ||
| Nevada | |||
|
|||
| Las Vegas | |||
|
|||
| Women's Cancer Center - La Canada | |||
| Nick M. Spirtos | Ph: 702-851-4672 | ||
| New Jersey | |||
|
|||
| Morristown | |||
|
|||
| Carol G. Simon Cancer Center at Morristown Memorial Hospital | |||
| Brian M Slomovitz | Ph: 973-971-5900 | ||
| New Mexico | |||
|
|||
| Albuquerque | |||
|
|||
| University of New Mexico Cancer Center | |||
| Teresa L Rutledge | Ph: 505-272-6972 | ||
| New York | |||
|
|||
| Brooklyn | |||
|
|||
| SUNY Downstate Medical Center | |||
| Ovadia Abulafia | Ph: 718-270-8216 | ||
| Email: sima.terebelo@downstate.edu | |||
| North Carolina | |||
|
|||
| Charlotte | |||
|
|||
| Blumenthal Cancer Center at Carolinas Medical Center | |||
| Robert Victor Higgins | Ph: 704-355-2884 | ||
| Concord | |||
|
|||
| Batte Cancer Center at Northeast Medical Center | |||
| Robert Victor Higgins | Ph: 704-355-2884 | ||
| Ohio | |||
|
|||
| Akron | |||
|
|||
| McDowell Cancer Center at Akron General Medical Center | |||
| Eric L. Jenison | Ph: 330-344-6348 | ||
| Summa Center for Cancer Care at Akron City Hospital | |||
| Vivian von Gruenigen | Ph: 330-375-6101 | ||
| Cleveland | |||
|
|||
| Case Comprehensive Cancer Center | |||
| Steven E. Waggoner | Ph: 800-641-2422 | ||
| Columbus | |||
|
|||
| Riverside Methodist Hospital Cancer Care | |||
| Jeffrey G. Bell | Ph: 614-566-4475 | ||
| Mentor | |||
|
|||
| Lake/University Ireland Cancer Center | |||
| Steven E. Waggoner | Ph: 800-641-2422 | ||
| Oklahoma | |||
|
|||
| Oklahoma City | |||
|
|||
| Oklahoma University Cancer Institute | |||
| Robert S. Mannel | Ph: 405-271-4272 | ||
| Email: julie-traylor@ouhsc.edu | |||
| Tulsa | |||
|
|||
| Cancer Care Associates-Yale | |||
| Robert S. Mannel | Ph: 405-271-4272 | ||
| Email: julie-traylor@ouhsc.edu | |||
| Pennsylvania | |||
|
|||
| Bryn Mawr | |||
|
|||
| Bryn Mawr Hospital | |||
| Paul B. Gilman | Ph: 484-476-2649 | ||
| Email: wellenbachj@mlhs.org | |||
| Paoli | |||
|
|||
| Cancer Center of Paoli Memorial Hospital | |||
| Paul B. Gilman | Ph: 484-476-2649 | ||
| Email: wellenbachj@mlhs.org | |||
| Philadelphia | |||
|
|||
| Gynecologic Oncology Group | |||
| Vivian von Gruenigen | Ph: 330-379-3514 | ||
| Email: vongruev@summahealth.org | |||
| Wynnewood | |||
|
|||
| CCOP - Main Line Health | |||
| Paul B. Gilman | Ph: 484-476-2649 | ||
| Email: wellenbachj@mlhs.org | |||
| Lankenau Cancer Center at Lankenau Hospital | |||
| Paul B. Gilman | Ph: 484-476-2649 | ||
| Email: wellenbachj@mlhs.org | |||
| Rhode Island | |||
|
|||
| Providence | |||
|
|||
| Women and Infants Hospital of Rhode Island | |||
| Paul A. DiSilvestro | Ph: 401-274-1122 | ||
| South Carolina | |||
|
|||
| Greenville | |||
|
|||
| Cancer Centers of the Carolinas - Faris Road | |||
| Larry E Puls | Ph: 864-241-6251 | ||
| CCOP - Greenville | |||
| Larry E Puls | Ph: 864-241-6251 | ||
| Seneca | |||
|
|||
| Cancer Centers of the Carolinas - Seneca | |||
| Larry E Puls | Ph: 864-241-6251 | ||
| Spartanburg | |||
|
|||
| Cancer Centers of the Carolinas - Spartanburg | |||
| Larry E Puls | Ph: 864-241-6251 | ||
| South Dakota | |||
|
|||
| Sioux Falls | |||
|
|||
| Avera Cancer Institute | |||
| Luis A Rojas-Espaillat | Ph: 800-657-4377 | ||
| Email: Jan.Healy@avera.org | |||
| Tennessee | |||
|
|||
| Chattanooga | |||
|
|||
| Chattanooga's Program in Women's Oncology | |||
| Stephen E DePasquale | Ph: 423-266-3636 | ||
| Texas | |||
|
|||
| Houston | |||
|
|||
| Memorial Hermann - Texas Medical Center | |||
| Larissa A Meyer | |||
| Email: sgriffin@gog.org | |||
| Wisconsin | |||
|
|||
| Green Bay | |||
|
|||
| Green Bay Oncology, Limited at St. Mary's Hospital | |||
| Jonathan E Tammela | Ph: 920-433-8889 | ||
| Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center | |||
| Jonathan E Tammela | Ph: 920-433-8889 | ||
| St. Vincent Hospital Regional Cancer Center | |||
| Jonathan E Tammela | Ph: 920-433-8889 | ||
| Madison | |||
|
|||
| University of Wisconsin Paul P. Carbone Comprehensive Cancer Center | |||
| David M Kushner | Ph: 877-405-6866 | ||
| Manitowoc | |||
|
|||
| Holy Family Memorial Medical Center Cancer Care Center | |||
| Jonathan E Tammela | Ph: 920-433-8889 | ||
| Marinette | |||
|
|||
| Bay Area Cancer Care Center at Bay Area Medical Center | |||
| Jonathan E Tammela | Ph: 920-433-8889 | ||
| Milwaukee | |||
|
|||
| Froedtert Hospital and Medical College of Wisconsin | |||
| William H Bradley | Ph: 414-805-4380 | ||
| New Richmond | |||
|
|||
| Cancer Center of Western Wisconsin | |||
| Joseph W Leach | Ph: 952-993-1517 | ||
| Email: MMCCOP@parknicollet.com | |||
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01372787
Information obtained from ClinicalTrials.gov on May 09, 2013
Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain
the same text. Minor
changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and
contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should
be directed to ClinicalTrials.gov.
Back to Top
